OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA?
| Autor: | Jaroenpuntaruk, V., Mashburn, A. |
|---|---|
| Zdroj: | In Annals of Allergy, Asthma & Immunology November 2022 129(5) Supplement:S109-S109 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|